Aram Hezel
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Pancreatic Neoplasms | 9 | 2006 | 46 |
Why?
| Biliary Tract Neoplasms | 3 | 2008 | 4 |
Why?
| Carcinoma, Pancreatic Ductal | 6 | 2006 | 5 |
Why?
| Protein-Serine-Threonine Kinases | 6 | 2002 | 105 |
Why?
| Pancreas | 3 | 2006 | 46 |
Why?
| Phosphatidylinositol 3-Kinases | 4 | 2007 | 67 |
Why?
| Gallbladder Neoplasms | 2 | 2010 | 7 |
Why?
| Cholangiocarcinoma | 2 | 2008 | 7 |
Why?
| Molecular Targeted Therapy | 1 | 2011 | 4 |
Why?
| Colorectal Neoplasms | 2 | 2007 | 55 |
Why?
| Cellular Structures | 1 | 2008 | 3 |
Why?
| Carcinoma | 1 | 2011 | 109 |
Why?
| Proto-Oncogene Proteins c-pim-1 | 1 | 2008 | 1 |
Why?
| Genomic Instability | 2 | 2005 | 12 |
Why?
| Telomere | 2 | 2005 | 10 |
Why?
| Genes, ras | 6 | 2001 | 24 |
Why?
| Neoplastic Syndromes, Hereditary | 1 | 2008 | 1 |
Why?
| Cystadenoma, Serous | 1 | 2008 | 2 |
Why?
| Proto-Oncogene Proteins | 4 | 2007 | 113 |
Why?
| ras Proteins | 3 | 2010 | 16 |
Why?
| Tumor Markers, Biological | 1 | 2008 | 112 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 121 |
Why?
| Genes, Tumor Suppressor | 3 | 2002 | 37 |
Why?
| Protein Kinases | 3 | 2007 | 64 |
Why?
| Animals | 18 | 1999 | 1031 |
Why?
| Deoxycytidine | 3 | 2008 | 20 |
Why?
| Neoplasms | 1 | 2008 | 239 |
Why?
| Signal Transduction | 7 | 2005 | 313 |
Why?
| Humans | 17 | 2005 | 1856 |
Why?
| Antineoplastic Agents | 3 | 2007 | 190 |
Why?
| Lung Neoplasms | 3 | 2006 | 159 |
Why?
| Mice | 13 | 1999 | 623 |
Why?
| Aging | 1 | 2005 | 275 |
Why?
| Liver Neoplasms | 2 | 2009 | 97 |
Why?
| Cell Polarity | 2 | 2008 | 24 |
Why?
| Tumor Suppressor Protein p53 | 4 | 2001 | 82 |
Why?
| Disease Models, Animal | 4 | 2006 | 349 |
Why?
| Peutz-Jeghers Syndrome | 2 | 2002 | 2 |
Why?
| Cell Transformation, Neoplastic | 3 | 2002 | 86 |
Why?
| Mice, Mutant Strains | 5 | 1999 | 77 |
Why?
| Adenocarcinoma | 3 | 2006 | 167 |
Why?
| Disease Progression | 4 | 2006 | 244 |
Why?
| Gene Deletion | 4 | 2002 | 121 |
Why?
| Tumor Suppressor Protein p14ARF | 3 | 2001 | 6 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2001 | 15 |
Why?
| Validation Studies as Topic | 1 | 2011 | 3 |
Why?
| Bile Ducts, Intrahepatic | 1 | 2011 | 8 |
Why?
| Bile Duct Neoplasms | 1 | 2011 | 8 |
Why?
| Mice, Transgenic | 3 | 2008 | 209 |
Why?
| TOR Serine-Threonine Kinases | 2 | 2007 | 21 |
Why?
| Cisplatin | 1 | 2011 | 43 |
Why?
| DNA Mutational Analysis | 1 | 2011 | 110 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 58 |
Why?
| Drug Therapy, Combination | 1 | 2011 | 189 |
Why?
| MAP Kinase Signaling System | 1 | 2010 | 56 |
Why?
| Pyrroles | 1 | 2009 | 13 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2009 | 11 |
Why?
| Pancreatic Ducts | 1 | 2008 | 3 |
Why?
| p21-Activated Kinases | 1 | 2008 | 3 |
Why?
| Mice, Knockout | 3 | 2002 | 265 |
Why?
| rho GTP-Binding Proteins | 1 | 2008 | 16 |
Why?
| Carcinoma, Hepatocellular | 1 | 2009 | 53 |
Why?
| Sirolimus | 1 | 2008 | 25 |
Why?
| Indoles | 1 | 2009 | 69 |
Why?
| Receptors, Notch | 1 | 2009 | 30 |
Why?
| Metaplasia | 1 | 2008 | 18 |
Why?
| Tight Junctions | 1 | 2008 | 10 |
Why?
| Neoplasms, Squamous Cell | 1 | 2008 | 9 |
Why?
| Fluorouracil | 1 | 2008 | 49 |
Why?
| Islets of Langerhans | 1 | 2008 | 26 |
Why?
| Carcinogens | 1 | 2008 | 40 |
Why?
| Cohort Studies | 1 | 2011 | 332 |
Why?
| Receptors, Growth Factor | 1 | 2007 | 23 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2007 | 17 |
Why?
| Energy Metabolism | 1 | 2008 | 80 |
Why?
| Magnesium Compounds | 1 | 2007 | 3 |
Why?
| Cytoskeleton | 1 | 2008 | 47 |
Why?
| Prednisolone | 1 | 2007 | 21 |
Why?
| Mutation | 2 | 2008 | 340 |
Why?
| Smad4 Protein | 1 | 2006 | 18 |
Why?
| src-Family Kinases | 1 | 2007 | 30 |
Why?
| Antibodies, Monoclonal | 1 | 2011 | 241 |
Why?
| Calcium Oxalate | 1 | 2007 | 7 |
Why?
| Protein Kinase Inhibitors | 1 | 2007 | 59 |
Why?
| Aged, 80 and over | 2 | 2009 | 599 |
Why?
| Protein Processing, Post-Translational | 1 | 2008 | 78 |
Why?
| Cats | 1 | 2007 | 71 |
Why?
| Receptor, Epidermal Growth Factor | 1 | 2007 | 54 |
Why?
| Biological Markers | 1 | 2009 | 262 |
Why?
| Phosphates | 1 | 2007 | 71 |
Why?
| Models, Biological | 2 | 2007 | 410 |
Why?
| Retinoblastoma Protein | 2 | 2001 | 26 |
Why?
| Genes, p53 | 1 | 2006 | 43 |
Why?
| Enzyme Activation | 1 | 2008 | 177 |
Why?
| Anti-Inflammatory Agents | 1 | 2007 | 80 |
Why?
| Epithelial Cells | 1 | 2008 | 135 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2008 | 176 |
Why?
| Cell Proliferation | 1 | 2008 | 227 |
Why?
| Prognosis | 1 | 2008 | 388 |
Why?
| Skin Neoplasms | 1 | 2008 | 97 |
Why?
| Phosphorylation | 1 | 2008 | 224 |
Why?
| Middle Aged | 4 | 2008 | 1161 |
Why?
| Pneumonia | 1 | 2006 | 85 |
Why?
| Aged | 3 | 2008 | 988 |
Why?
| Intestinal Polyps | 1 | 2002 | 10 |
Why?
| Treatment Outcome | 2 | 2007 | 661 |
Why?
| Female | 5 | 2007 | 1643 |
Why?
| Adult | 3 | 2008 | 1317 |
Why?
| Cell Line, Tumor | 3 | 2006 | 208 |
Why?
| Drug Resistance, Neoplasm | 2 | 2008 | 32 |
Why?
| Male | 4 | 2008 | 1553 |
Why?
| Melanoma | 1 | 2001 | 87 |
Why?
| Carrier Proteins | 1 | 2002 | 177 |
Why?
| Mutagenesis | 1 | 1999 | 74 |
Why?
| DNA Repair | 1 | 1999 | 47 |
Why?
| Administration, Oral | 2 | 2007 | 170 |
Why?
| Phenotype | 2 | 2006 | 303 |
Why?
| DNA-Binding Proteins | 1 | 1999 | 204 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2001 | 126 |
Why?
| Chemokine CXCL12 | 1 | 2009 | 24 |
Why?
| Cyclic S-Oxides | 1 | 2009 | 1 |
Why?
| Thiadiazoles | 1 | 2009 | 8 |
Why?
| Oncogene Protein v-akt | 1 | 2008 | 4 |
Why?
| Cell Line, Transformed | 1 | 2008 | 52 |
Why?
| Mice, Nude | 1 | 2008 | 72 |
Why?
| Genomics | 1 | 2008 | 36 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 14 |
Why?
| Neoplasm Staging | 1 | 2010 | 125 |
Why?
| Combined Modality Therapy | 1 | 2010 | 219 |
Why?
| Neoplasm Invasiveness | 1 | 2008 | 105 |
Why?
| Survival Rate | 1 | 2010 | 250 |
Why?
| Epidermis | 1 | 2008 | 30 |
Why?
| Cat Diseases | 1 | 2007 | 5 |
Why?
| Stromal Cells | 1 | 2007 | 41 |
Why?
| Urinalysis | 1 | 2007 | 17 |
Why?
| Neoplasm Metastasis | 1 | 2008 | 112 |
Why?
| Urinary Calculi | 1 | 2007 | 21 |
Why?
| Cross-Over Studies | 1 | 2007 | 82 |
Why?
| Interleukin-6 | 1 | 2009 | 145 |
Why?
| Cell Movement | 1 | 2008 | 163 |
Why?
| Homozygote | 1 | 2006 | 68 |
Why?
| Alleles | 1 | 2006 | 108 |
Why?
| Cyclooxygenase 2 | 1 | 2007 | 77 |
Why?
| Macrophages, Alveolar | 1 | 2006 | 44 |
Why?
| Stem Cells | 1 | 2009 | 107 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2006 | 68 |
Why?
| DNA Primers | 1 | 2006 | 208 |
Why?
| Cell Line | 1 | 2009 | 375 |
Why?
| Transforming Growth Factor beta | 1 | 2006 | 99 |
Why?
| NF-kappa B | 1 | 2007 | 114 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 243 |
Why?
| Magnetic Resonance Imaging | 1 | 2009 | 294 |
Why?
| Culture Media, Conditioned | 1 | 2002 | 45 |
Why?
| Gene Targeting | 1 | 2002 | 51 |
Why?
| Cell Aging | 1 | 2002 | 31 |
Why?
| Immunohistochemistry | 1 | 2006 | 355 |
Why?
| cdc25 Phosphatases | 1 | 2001 | 1 |
Why?
| Base Sequence | 1 | 2006 | 371 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2001 | 29 |
Why?
| S Phase | 1 | 2001 | 29 |
Why?
| Cyclin D1 | 1 | 2001 | 22 |
Why?
| G1 Phase | 1 | 2001 | 27 |
Why?
| Gene Silencing | 1 | 2001 | 32 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 31 |
Why?
| Cyclins | 1 | 2001 | 28 |
Why?
| Cell Differentiation | 1 | 2006 | 262 |
Why?
| In Situ Hybridization | 1 | 2001 | 135 |
Why?
| Xeroderma Pigmentosum Group A Protein | 1 | 1999 | 1 |
Why?
| Chimera | 1 | 1999 | 22 |
Why?
| Lac Operon | 1 | 1999 | 38 |
Why?
| Fibroblasts | 1 | 2002 | 179 |
Why?
| Genes, Reporter | 1 | 1999 | 111 |
Why?
| Proteins | 1 | 2001 | 192 |
Why?
| Age Factors | 1 | 1999 | 480 |
Why?
| RNA, Messenger | 1 | 2002 | 394 |
Why?
| Liver | 1 | 1999 | 248 |
Why?
| Brain | 1 | 1999 | 305 |
Why?
|
|
Hezel's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
